Retrospective Study
Copyright ©The Author(s) 2025.
World J Cardiol. Jul 26, 2025; 17(7): 109044
Published online Jul 26, 2025. doi: 10.4330/wjc.v17.i7.109044
Table 1 Comparison of baseline data between groups, n (%)
Baseline data
Survival group (n = 30)
Death group (n = 18)
χ2/t
P value
Gender17 (56.7)11 (61.1)0.0910.762
Age (years) (mean ± SD)65.1 ± 6.771 ± 11.22.3030.026
BMI (kg/m2) (mean ± SD)23.8 ± 3.623.1 ± 3.0-0.740.463
Smoking history14 (46.7)9 (50.0)0.050.823
Drinking history21 (70)13 (72.2)0.0270.87
HTN17 (56.7)4 (22.2)5.4240.02
Hyperlipidemia20 (66.7)13 (72.2)0.1620.688
T2DM19 (63.3)11 (61.1)0.0240.878
Apoplexy25 (83.3)17 (94.4)1.270.26
Angina pectoris 11 (36.7)8 (44.4)0.2850.594
OMI17 (56.7)6 (33.3)2.4540.117
Liver dysfunction9 (30.0)13 (72.2)8.0780.004
SBP (mmHg) (mean ± SD)105.3 ± 16.8102.3 ± 21.4-0.550.585
DBP (mmHg) (mean ± SD)72.5 ± 13.172.6 ± 19.80.0230.981
MBP (mmHg) (mean ± SD)83.5 ± 12.079.1 ± 18.1-0.9950.325
HR (times/minute) (mean ± SD)94.9 ± 20.2102.1 ± 15.01.2940.202
Acute extensive anterior MI13 (43.3)13 (72.2)3.7820.052
Early VSR23 (76.7)18 (100)4.9170.073
Killip ≥ III19 (63.3)15 (83.3)2.1780.14
Combined arrhythmia9 (30.0)5 (27.8)0.0270.87
Stent implantation15 (50.0)9 (50.0)01
PaO2/FiO2 ≤ 2003 (10.0)1 (5.6)0.2911